News, views and contacts from the global Pharmaceutical industry

Pfanstiehl: Press Releases

Make An Enquiry

Pfanstiehl Will Attend PepTalk: the Protein Science Week Tuesday, January 13, 2015 by Pfanstiehl Pfanstiehl will be attending PepTalk: the Protein Science Week from 19-23 January 2015 in San...

Pfanstiehl Launches cGMP-produced, Parenteral Grade Mannitol for Pharmaceutical Formulations Monday, December 01, 2014 by Pfanstiehl Pfanstiehl has announced the launch of a new high-purity, low-endotoxin, Mannitol, which is manufactured in the US under strict current good manufacturing practices (cGMP) and ICH Q7...

Pfanstiehl Launches cGMP-produced Mannose for Cell Culture Media Optimization and Glycoprotein Biosynthesis Thursday, October 02, 2014 by Pfanstiehl Pfanstiehl has announced the launch of cGMP-produced, high purity Mannose (USP/NF, EP), manufactured in the US under ICH Q7 compliant conditions....

Pfanstiehl Gearing Up for Potent API Expansion Thursday, September 11, 2014 by Pfanstiehl Pfanstiehl is aggressively investing in its potent API contract manufacturing capabilities at its US-based cGMP facility located north of Chicago, US....

Pfanstiehl Launches cGMP-produced, Non-Animal-Derived Galactose for Optimizing Cell Culture Media Monday, July 07, 2014 by Pfanstiehl Pfanstiehl just announced the launch of its new high purity, low endotoxin, non-animal-derived Galactose (USP/NF, EP), manufactured in the US under strict cGMP, ICH Q7-compliant conditions....